Ameriprise Financial Announces Schedule for First Quarter 2024 Investor Conference Call
Ameriprise Financial Announces Schedule for First Quarter 2024 Investor Conference Call
Ameriprise Financial, Inc. (NYSE: AMP) plans to announce its first quarter 2024 financial results on Monday, April 22, 2024 after the close of the New York Stock Exchange. The company will host a conference call to discuss the results on Tuesday, April 23, 2024 at 9:00 a.m. ET.
A live audio webcast of the conference call, as well as presentation slides and audio replay, will be available on the Ameriprise Financial Investor Relations website at ir.ameriprise.com.
At Ameriprise Financial, we have been helping people feel confident about their financial future for more than 125 years. With extensive investment advice, asset management and insurance capabilities and a nationwide network of more than 10,000 financial advisors, we have the strength and expertise to serve the full range of individual and institutional investors' financial needs.
© 2024 Ameriprise Financial, Inc. All rights reserved.
Paul Johnson
Ameriprise Financial
612.671.0625
paul.w.johnson@ampf.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240408266580/en/
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Amazon Earnings: AWS Growth Accelerates and Profit Margins Improve
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?